Oncolytics Biotech ONCY
NASDAQ ONCY
$0.51 +0.01 (+2.57%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oncolytics Biotech (ONCY) Operating Margin (2016 - 2025)

Updated

Oncolytics Biotech (ONCY) posted Operating Margin of -765.44% for Q2 2017, down 1133.76 percentage points from 368.32% a year earlier.

Analysis

Oncolytics Biotech (ONCY) Operating Margin (2016 - 2025) Analysis & Trends

For the trailing twelve months through Jun 30, 2017, Operating Margin at Oncolytics Biotech was -809.42%, down 825.48 percentage points year-over-year.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Oncolytics Biotech 60.94 Mn 32.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -6,196.53%
Jun 30, 2017 -765.44%
Jun 30, 2016 368.32%
API Access

Oncolytics Biotech Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ONCY&period=max&api_key=YOUR_API_KEY